BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24945431)

  • 1. ABO blood group and von Willebrand factor: biological implications.
    Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
    Clin Chem Lab Med; 2014 Sep; 52(9):1273-6. PubMed ID: 24945431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet von Willebrand factor--structure, function and biological importance.
    McGrath RT; McRae E; Smith OP; O'Donnell JS
    Br J Haematol; 2010 Mar; 148(6):834-43. PubMed ID: 20067560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor.
    Sousa NC; Anicchino-Bizzacchi JM; Locatelli MF; Castro V; Barjas-Castro ML
    Haematologica; 2007 Feb; 92(2):236-9. PubMed ID: 17296574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.
    Millar CM; Riddell AF; Brown SA; Starke R; Mackie I; Bowen DJ; Jenkins PV; van Mourik JA
    Thromb Haemost; 2008 May; 99(5):916-24. PubMed ID: 18449422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor: another janus-faced hemostasis protein.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2008 Oct; 34(7):663-9. PubMed ID: 19085767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
    Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
    J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels.
    Davies JA; Collins PW; Hathaway LS; Bowen DJ
    Acta Haematol; 2009; 121(2-3):98-101. PubMed ID: 19506354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.
    Ward SE; O'Sullivan JM; O'Donnell JS
    Blood; 2020 Dec; 136(25):2864-2874. PubMed ID: 32785650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance mechanisms of von Willebrand factor and factor VIII.
    Lenting PJ; VAN Schooten CJ; Denis CV
    J Thromb Haemost; 2007 Jul; 5(7):1353-60. PubMed ID: 17425686
    [No Abstract]   [Full Text] [Related]  

  • 13. ABO blood group, hypercoagulability, and cardiovascular and cancer risk.
    Franchini M; Favaloro EJ; Targher G; Lippi G
    Crit Rev Clin Lab Sci; 2012; 49(4):137-49. PubMed ID: 22856614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of von Willebrand factor in haemostasis and thrombosis.
    Reininger AJ
    Haemophilia; 2008 Nov; 14 Suppl 5():11-26. PubMed ID: 18786007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications.
    Hilbert L; Federici AB; Baronciani L; Dallagiovanna S; Mazurier C
    Haematologica; 2004 Sep; 89(9):1128-33. PubMed ID: 15377475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.
    O'Donnell J; Laffan MA
    Transfus Med; 2001 Aug; 11(4):343-51. PubMed ID: 11532189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostasis in patients of different ABO blood groups.
    Lisander B; Hahn R
    Anesth Analg; 2002 Jul; 95(1):254-5; author reply 255. PubMed ID: 12088984
    [No Abstract]   [Full Text] [Related]  

  • 18. [Von Willebrand factor and ADAMTS13 balancing primary haemostasis].
    Schneppenheim R; Budde U
    Hamostaseologie; 2011 Nov; 31(4):275-80. PubMed ID: 21792464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia.
    Cohen W; Castelli C; Alessi MC; Aillaud MF; Bouvet S; Saut N; Brunet D; Barthet MC; Tregouet DA; Lavigne G; Morange PE
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):2021-8. PubMed ID: 22628432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.